Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening

被引:59
作者
Darlin, Lotten [1 ]
Borgfeldt, Christer [1 ]
Forslund, Ola [2 ]
Henic, Emir [1 ]
Hortlund, Maria [2 ,3 ,4 ,5 ]
Dillner, Joakim [3 ,4 ,5 ]
Kannisto, Paivi [1 ,6 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Obstet & Gynaecol, Lund, Sweden
[2] Lund Univ, Skane Univ Hosp, Dept Lab Med, Lund, Sweden
[3] Karolinska Hosp & Inst, Dept Lab Med, Stockholm, Sweden
[4] Karolinska Hosp & Inst, Dept Med Epidemiol, Stockholm, Sweden
[5] Karolinska Hosp & Inst, Dept Biostat, Stockholm, Sweden
[6] Kliniken Essen Mitte, Dept Obstet & Gynaecol, D-45136 Essen, Germany
关键词
Screening; Non-attendance; HPV testing; Vaginal smear; Cytology; Self-collected vaginal smear; HIGH-RISK HPV; HUMAN-PAPILLOMAVIRUS DNA; CERVICOVAGINAL LAVAGE; NON-ATTENDANCE; FOLLOW-UP; CANCER; PREVALENCE; ACCURACY; REASONS; SWEDEN;
D O I
10.1016/j.jcv.2013.06.029
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Many cervical cancers occur among women who have not attended cervical screening. Strategies to reach non-attending women may improve the effectiveness of cervical screening programmes. Objective: To compare the responses among long-term non-attending women to either (i) HPV-testing of a self-collected vaginal sample, or (ii) cytological screening with a flexible no-fee appointment for sampling at an outpatient clinic. Study design: Among the 242,000 women aged 32-65 years in Southern Sweden, we identified 28,635 women who had not had any cervical smears taken for >9 years. We randomized 1000 women to invitation to HPV self-sampling, and 500 women to flexible outpatient clinic appointments. Responding women received a questionnaire about their reasons for previous non-attendance. Results: The response rate to HPV self-sampling was three times higher than the flexible outpatient clinic invitations (147/1000 women (14.7%) compared to 21/500 (4.2%) p < 0.0001). High-risk (hr)-HPV was found in 10/147 self-sampled women (6.9%). 7/10 hr-HPV-positive women attended colposcopy, but no HSIL was found. Among the clinic-sampled women, 2/21 had hr-HPV and 1/21 had HSIL. Reasons for not attending were "uncomfortable with vaginal examination", "feel healthy", "lack of time" and "experience of unfriendly health workers". Conclusions: Although the response rate was low for both interventions, the invitation to vaginal HPV self-sampling was more effective for increasing the coverage of the screening programme. The fact that "uncomfortable with vaginal examination" was the most common reason for non-attending suggests that self-sampling could be further explored as a strategy to increase the coverage of cervical screening programmes. (C) 2013 Elsevier B. V. All rights reserved.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 38 条
  • [1] Cervical screening in England: The past, present, and future
    Albrow, Rebecca
    Kitchener, Henry
    Gupta, Nalini
    Desai, Mina
    [J]. CANCER CYTOPATHOLOGY, 2012, 120 (02) : 87 - 96
  • [2] Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden
    Andrae, Bengt
    Kemetli, Levent
    Sparen, Par
    Silfverdal, Lena
    Strander, Bjorn
    Ryd, Walter
    Dillner, Joakim
    Tornberg, Sven
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09): : 622 - 629
  • [3] Screening and cervical cancer cure: population based cohort study
    Andrae, Bengt
    Andersson, Therese M-L
    Lambert, Paul C.
    Kemetli, Levent
    Silfverdal, Lena
    Strander, Bjorn
    Ryd, Walter
    Dillner, Joakim
    Tornberg, Sven
    Sparen, Par
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [4] European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document
    Arbyn, M.
    Anttila, A.
    Jordan, J.
    Ronco, G.
    Schenck, U.
    Segnan, N.
    Wiener, H.
    Herbert, A.
    von Karsa, L.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (03) : 448 - 458
  • [5] Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear
    Arora, R
    Kumar, A
    Prusty, BK
    Kailash, U
    Batra, S
    Das, BC
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 121 (01) : 104 - 109
  • [6] Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3
  • [7] Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
    Bulkmans, N. W. J.
    Berkhof, J.
    Rozendaal, L.
    van Kemenade, F. J.
    Boeke, A. J. P.
    Bulk, S.
    Voorhorst, F. J.
    Verheijen, R. H. M.
    Groningen, Kvan
    Boon, M. E.
    Ruitinga, W.
    van Ballegooijen, M.
    Snijders, P. J. F.
    Meijer, C. J. L. M.
    [J]. LANCET, 2007, 370 (9601) : 1764 - 1772
  • [8] High-risk HPV type-specific clearance rates in cervical screening
    Bulkmans, N. W. J.
    Berkhof, J.
    Bulk, S.
    Bleeker, M. C. G.
    van Kemenade, F. J.
    Rozendaal, L.
    Snijders, P. J. F.
    Meijer, C. J. L. M.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (09) : 1419 - 1424
  • [9] Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada
    Burchell, AN
    Richardson, H
    Mahmud, SM
    Trottier, H
    Tellier, PP
    Hanley, J
    Coutlée, F
    Franco, EL
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (06) : 534 - 543
  • [10] Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity
    Darlin, Lotten
    Borgfeldt, Christer
    Forslund, Ola
    Henic, Emir
    Dillner, Joakim
    Kannisto, Paivi
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2013, 56 (01) : 52 - 56